Bottom line
How much do TMED and QAAGZX overlap?
46% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 39.4% of TMED's assets and 30.4% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.
QAAGZX holds far more positions (277 vs 102), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings TMED and QAAGZX have in common
| Holding | % of TMED | % of QAAGZX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 16.71% | 14.06% | 14.06% |
| Unitedhealth Group Inc | 6.52% | 5.88% | 5.88% |
| Gilead Sciences Inc | 4.44% | 2.79% | 2.79% |
| Thermo Fisher Scientific Inc | 4.11% | 2.53% | 2.53% |
| Danaher Corp | 2.96% | 1.44% | 1.44% |
| Intuitive Surgical Inc | 2.43% | 1.89% | 1.89% |
| Stryker Corp | 2.22% | 1.78% | 1.78% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in TMED
- Cencora Inc — 2.75%
- Agilent Technologies Inc — 2.61%
- Alnylam Pharmaceuticals Inc — 2.60%
- Insulet Corp — 2.38%
- Dyne Therapeutics Inc — 2.03%
- Elanco Animal Health Inc — 1.91%
- Pfizer Inc — 1.91%
- Cytokinetics Inc — 1.69%
- Waters Corp — 1.68%
- West Pharmaceutical Services — 1.65%
- Ascendis Pharma A/s — 1.60%
- Biogen Inc — 1.55%
- Mckesson Corp — 1.46%
- Dexcom Inc — 1.46%
- Immunome Inc — 1.38%
Only in QAAGZX
- Johnson & Johnson — 6.64%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
- Amgen Inc — 1.80%
- Elevance Health Inc — 1.54%
- Natera Inc — 1.44%
- Guardant Health Inc — 1.22%
- Cardinal Health Inc — 1.04%
- Royalty Pharma Plc- Cl A — 0.97%
- Tenet Healthcare Corp — 0.94%
- Cvs Health Corp — 0.93%
- Kymera Therapeutics Inc — 0.89%
Asset mix
| Asset type | TMED | QAAGZX |
|---|---|---|
| Stocks | 99.3% | 96.9% |
| Preferred stock | — | 2.2% |
| Cash & short-term funds | 0.7% | 0.9% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | TMED | QAAGZX |
|---|---|---|
| US | 93.3% | 92.3% |
| GB | — | 1.8% |
| DK | 1.6% | 0.7% |
| DE | 1.6% | — |
| KY | 1.1% | 0.5% |
| NL | 0.9% | 1.0% |
| IE | — | 0.8% |
| BM | — | 0.7% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do TMED and QAAGZX overlap?
What stocks do TMED and QAAGZX have in common?
Should I own both TMED and QAAGZX?
Which holds more stocks, TMED or QAAGZX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.